Abstract
Since its first discovery in late 2019, coronavirus disease 2019 (COVID-19) has been
a global burden associated with significant morbidity and mortality. COVID-19 has
been correlated with the development of hypercoagulable state that predisposes the
patients to a higher risk of thromboembolism. Current evidence suggests higher incidence
of thrombosis, particularly venous thrombosis, among hospitalized COVID-19 patients,
mostly with critical illness. On the other hand, there is currently no data regarding
the incidence of vivid thrombosis in ambulatory patients with mild COVID-19 and the
incidence of concomitant arterial and venous thrombosis in COVID-19 is extremely rare.
Herein, we describe catastrophic outcomes of concomitant lower limb arterial and venous
thrombosis in a patient with mild COVID-19. This report highlights the occurrence
of concomitant arterial and venous thrombosis in ambulatory setting and that this
phenomenon resulted in catastrophic clinical consequences.
Keywords
acute limb ischemia - deep vein thrombosis - mild COVID-19 - ischemia-reperfusion
injury - thrombectomy - ambulatory - anticoagulation
